'Diabetes Drug Pricing Transparency Act of 2020'; disclosure of diabetes prescription drug pricing; require
Summary
A BILL to be entitled an Act to amend Title 33 of the Official Code of Georgia Annotated, relating to insurance, so as to require disclosure of diabetes prescription drug pricing; to provide for a short title; to provide for legislative findings; to provide for definitions; to provide for a listing of diabetes prescription drugs; to provide for drug manufacturer and pharmacy benefits manager report forms and insurer pricing reports; to provide for certain other reports; to provide for penalties; to amend Chapter 1 of Title 10 of the Official Code of Georgia Annotated, relating to selling and other trade practices, so as to provide for penalties regarding unfair or deceptive practices in consumer transactions; to provide for related matters; to provide for an effective date and applicability; to repeal conflicting laws; and for other purposes.
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2020
Committee Review
Floor Vote
Governor
Introduced Feb 24, 2020
Last action Feb 25, 2020
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Feb 25, 2020
Committee
Senate Read and Referred
upper
5 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Burt Jones
RRepublican
P
Dean Burke
RRepublican
P
Lee Anderson
RRepublican
P
Matt Brass
RRepublican
P
P. K. Martin IV
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 433
Scope: GA
Hi! I can help you understand SB 433. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline